Twitter Beğeni Hilesi

The biology of smell is a mystery — AI is helping to solve it nature.com/articles/d4158…

Register now for Measuring Toxicity in Reproductive Organs during Oncology Drug Development – a 2 Day Virtual FDA-ASCO Workshop, Oct. 1 and 8. Details here: fda.gov/news-events/fd…. Register here⤵️ fda.zoomgov.com/webinar/regist… #FDAASCOWkshp24

🚨Pleased to share the pre-proof version of the editorial commentary just published ESMO - Eur. Oncology flagship journal Annals of Oncology 👉 Optimizing Tomorrow’s Drug Development with Project Optimus: Precision Dosing IS Precision Oncology 🎯💊💉#Oncology #DrugDevelopment

🚨Nice work by Neeraj Agarwal, MD, FASCO & colleagues highlighting the need for dose optimization in drug development! More belzutifan- HIF-2α inhibitor (200 mg vs 120 mg QD) was not better 🎯That's why there is Project Optimus. 📈 cc Neli Ulrich, PhD Sumanta K. Pal, MD, FASCO Petros Grivas 👉Learn about the

Read our Sept/Oct issue! 📕 acsjournals.onlinelibrary.wiley.com/toc/15424863/2… In this issue: 🔵 Farhad Islami, MD PhD et al on potentially preventable cancers in the US 🔵 Vivek Subbiah, MD et al on tissue-agnostic #PrecisionOncology 🔵 Stacy Loeb, MD on cancer misinformation on social media OncoAlert

Sustained Clinical Benefit and Intracranial Activity of Tarlatamab in Previously Treated Small Cell Lung Cancer: DeLLphi-300 Trial Update | Journal of Clinical Oncology ascopubs.org/doi/10.1200/JC…

If you’re in your 40s or 60s and suddenly feel older, it might not be all in your head. Scientists suggest we age in “waves” at certain points of our lives ⁦The Wall Street Journal⁩ Link to the paper ⁦Nature Medicine⁩ nature.com/articles/s4159… wsj.com/health/wellnes…

Teclistamab-Induced Remission in Refractory Systemic Lupus Erythematosus | New England Journal of Medicine A woman with aggressive refractory systemic lupus erythematosus was treated with a short course of the bispecific antibody teclistamab (anti–B-cell maturation antigen and

When a cancer drug finds efficacy in a non-cancerous condition, it will generally work even more effectively than it does in cancer…. But, really, this is evidence that CD19 CAR T cells might be overkill for autoimmune conditions if you can just use B cell modulation instead…

My second book “THE CANCER JOURNEY” launches 9/24/24 & is available to pre-order a.co/d/f0mwZCZ I leverage storytelling to explain & simplify everything related to cancer from A-Z; written in an easy to read & understand language so it reaches everyone. Check it out.

What an honor to give the #Quagliana Endowed Lectureship at University of Utah/University of Utah Department of Internal Medicine! Many thanks to Neeraj Agarwal, MD, FASCO for the invitation. Beyond the lecture, was delighted to sit in with his research team (Umang Swami Georges Gebrael Benjamin L Maughan Vinay Mathew Thomas Chadi Hage Chehade Zeynep Irem Ozay, MD et al)

Here's a Twitter List of all the #ESMO24Ambassadors for an easy #ESMO24 follow : 👇 x.com/i/lists/183205… … Well done Jon Lim and Lizzy Smyth for 🇬🇧 representation

🚨 Countdown starts for the #ESMO24 meeting in Barcelona! Super thrilled to be one of the ESMO ambassadors alongside amazing colleagues. 🌟 👉Please follow them all & ESMO - Eur. Oncology 👉In 2024, if you can't be there in person, no worries! Just follow ESMO - Eur. Oncology for all the latest updates

1️⃣ EPoster EP06.B18 by Madhan Srinivasan Kumar, MD who presents findings on the biomarker landscape of antibody-drug conjugates (ADCs) & bispecific antibodies (BsAbs) in clinical trials for #lungcancer at IASLC #WCLC24 #lcsm 👀 Key highlights: •47 clinical trials reviewed 📝 •Biomarker use

What a lineup of great colleagues as #ESMOAmbassadors! Only 1 week before ESMO - Eur. Oncology #ESMO24 in Barcelona! Finishing posters, presentations, adding meetings, & can’t wait for new data improving cancer outcomes! Petros Grivas Erika Hamilton, MD Vivek Subbiah, MD Stephen V Liu, MD Jarushka Naidoo

🚨Such a delight to host a JAMA Oncology PODCAST with the amazing Eileen M O’Reilly Memorial Sloan Kettering Cancer Center - we talk about how an #AI based classifier reclassified approximately 20% of cases with pancreatic cancer. 👉🏼#immunotherapy for patients with Lynch syndrome or somatic MSI-H PanCAN

⭐️☀️🌞Fantastic day & amazing weather in Nashville, TN for a morning walk with the melanoma clinical research #Dreamteam Sarah Cannon Docs SCRI Oncology Partners supporting the AIM at Melanoma Foundation for melanoma awareness, education & research Meredith McKean MD, MPH Ishwaria Subbiah, MD MS FASCO Erika Hamilton, MD

☀️Amazing day for a morning walk to support melanoma research - melanoma 5k walk ! Slip! Slop! Slap! and Wrap! h/t American Cancer Society If you are going to be in the sun, this catchphrase can help you remember some of the key steps you can take to protect yourself from UV rays: